News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Editas Medicine
NEWS
JOBS
IN THE PRESS
AWARDS
NEWS
Genetown
Editas Medicine Stock Surge Driven by Supportive Friends and Their Bank Accounts
March 9, 2016
·
2 min read
Business
Editas Medicine, Juno Therapeutics Hammer Out $727 Million CAR T R&D Deal
May 27, 2015
·
10 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Editas Medicine Announces Updated Presentation Time for Upcoming Investor Conference
May 29, 2026
·
1 min read
Press Releases
Editas Medicine Announces Pricing of Up to $319.4 Million Public Offering
May 26, 2026
·
5 min read
Press Releases
Editas Medicine Presents EDIT-401 Preclinical Data Demonstrating Robust Reductions in LDL-C, Lp(a), and ApoB in Non-Human Primates at the 94th European Atherosclerosis Society Congress
May 26, 2026
·
5 min read
Press Releases
Editas Medicine Announces Proposed Public Offering - May 26, 2026
May 26, 2026
·
4 min read
Press Releases
Editas Medicine Reports New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at the American Society of Gene and Cell Therapy 2026 Annual Meeting
May 14, 2026
·
6 min read
Press Releases
Editas Medicine Announces First Quarter 2026 Results and Business Updates
May 5, 2026
·
10 min read
Press Releases
Editas Medicine to Present New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at Upcoming Scientific Conferences
April 28, 2026
·
3 min read
Press Releases
Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference
March 27, 2026
·
4 min read
Press Releases
Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates
March 9, 2026
·
10 min read
Press Releases
Editas Medicine to Participate in Upcoming March 2026 Investor Conferences
February 23, 2026
·
1 min read
